Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

Trial Profile

Intrapleural DNase and Tissue Plasminogen Activator in Pediatric Empyema (DTPA Trial)

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Dec 2017

At a glance

  • Drugs Dornase alfa (Primary) ; Alteplase
  • Indications Embolism and thrombosis; Empyema
  • Focus Therapeutic Use
  • Acronyms DTPA
  • Most Recent Events

    • 20 Dec 2017 Status changed from recruiting to completed.
    • 13 Feb 2017 Planned End Date changed from 1 Apr 2015 to 1 Dec 2017.
    • 13 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top